From these studies, it appears that upregulation of Ca2+-dependent MLCK activity and RhoA/PKC-dependent inhibition of MLCP is a general mechanism involved in smooth muscle hypercontractility in diabetes. This evidence concerns the gene PRRT2 and diabetes mellitus.